Literature DB >> 4022870

Oncogenic osteomalacia: strange tumours in strange places.

D Weiss, R S Bar, N Weidner, M Wener, F Lee.   

Abstract

Two patients presented with hypophosphataemic osteomalacia and were subsequently found to have small tumours unusual histopathology and location causing the osteomalacia. Each tumour was found after an intensive search for occult masses. Studies of vitamin D metabolism and renal tubular function before and after surgery yielded further insight into the pathophysiology of oncogenic osteomalacia. These cases demonstrate that microscopic quantities of tumour are capable of causing the syndrome and further illustrate the high index of suspicion often necessary to locate causative tumours in patients with hypophosphataemic osteomalacia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4022870      PMCID: PMC2418222          DOI: 10.1136/pgmj.61.714.349

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  Tumor-induced vitamin D-resistant hypophosphatemic osteomalacia associated with proximal renal tubular dysfunction and 1,25-dihydroxyvitamin D deficiency.

Authors:  Y Fukumoto; S Tarui; K Tsukiyama; K Ichihara; K Moriwaki; K Nonaka; T Mizushima; Y Kobayashi; S Dokoh; M Fukunaga; R Morita
Journal:  J Clin Endocrinol Metab       Date:  1979-12       Impact factor: 5.958

2.  Tumor-induced osteomalacia and rickets: a surgically curable syndrome. Report of two cases.

Authors:  R J Linovitz; D Resnick; P Keissling; J J Kondon; B Sehler; R J Nejdl; J H Rowe; L J Deftos
Journal:  J Bone Joint Surg Am       Date:  1976-04       Impact factor: 5.284

3.  Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion.

Authors:  L A Baxter; H F DeLuca
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

4.  Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.

Authors:  M K Drezner; M N Feinglos
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

5.  Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia.

Authors:  D J Evans; J G Azzopardi
Journal:  Lancet       Date:  1972-02-12       Impact factor: 79.321

6.  Oncogenic hypophosphatemic osteomalacia.

Authors:  Z S Agus
Journal:  Kidney Int       Date:  1983-07       Impact factor: 10.612

7.  Nomogram for derivation of renal threshold phosphate concentration.

Authors:  R J Walton; O L Bijvoet
Journal:  Lancet       Date:  1975-08-16       Impact factor: 79.321

8.  Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.

Authors:  L C Aschinberg; L M Solomon; P M Zeis; P Justice; I M Rosenthal
Journal:  J Pediatr       Date:  1977-07       Impact factor: 4.406

9.  Vitamin D metabolites and bone mineralization in man.

Authors:  P Bordier; H Rasmussen; P Marie; L Miravet; J Gueris; A Ryckwaert
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

10.  Localization of 25-hydroxyvitamin D3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron.

Authors:  H Kawashima; S Torikai; K Kurokawa
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  10 in total

1.  Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance.

Authors:  Pallavi Suryawanshi; Manish Agarwal; Rahul Dhake; Saral Desai; Bharat Rekhi; Kishor B Reddy; Nirmala Ajit Jambhekar
Journal:  Skeletal Radiol       Date:  2011-05-01       Impact factor: 2.199

2.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

3.  Oncogenic osteomalacia due to phosphaturic mesenchymal tumor of the craniofacial sinuses.

Authors:  Giuseppe Guglielmi; Michele Bisceglia; Alfredo Scillitani; Andrew L Folpe
Journal:  Clin Cases Miner Bone Metab       Date:  2011-05

4.  Metastatic prostate cancer presenting as tumour-induced osteomalacia.

Authors:  Awo Akosua K Layman; Shivam Joshi; Sanjeev Shah
Journal:  BMJ Case Rep       Date:  2019-07-16

5.  Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia.

Authors:  Regina S Bower; Wilson P Daugherty; Caterina Giannini; Ian F Parney
Journal:  Surg Neurol Int       Date:  2012-12-14

Review 6.  Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.

Authors:  Victoria L Woo; Regina Landesberg; Erik A Imel; Steven R Singer; Andrew L Folpe; Michael J Econs; Taeyun Kim; Lara R Harik; Thomas P Jacobs
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-10-14

7.  Oncogenic osteomalacia: Problems in diagnosis and long-term management.

Authors:  Ish K Dhammi; Anil K Jain; Ajay Pal Singh; Puneet Mishra; Saurabh Jain
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

8.  Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.

Authors:  I M Yang; Y K Park; Y J Hyun; D Y Kim; J T Woo; S W Kim; J W Kim; Y S Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

9.  Diagnostic importance of contrast enhanced (18)F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: Our experience.

Authors:  Avani S Jain; Simon Shelley; Indirani Muthukrishnan; Shilpa Kalal; Jaykanth Amalachandran; Sureshkumar Chandran
Journal:  Indian J Nucl Med       Date:  2016 Jan-Mar

10.  Tumor-induced osteomalacia with the culprit lesion located in the palm: a case report.

Authors:  Yanying Qian; Zhijuan Dai; Cong Zhu; Luya Ruan; Saroj Thapa; Chaoming Wu
Journal:  J Int Med Res       Date:  2019-03-12       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.